The first part of this series covered updates on traditional psychotropics—lithium, anticonvulsants, antipsychotics, and more. Here, Part 2 examines anti-inflammatories, natural supplements, and mitochondrial therapies.
Chris Aiken, MD
For most patients, bipolar is a disorder of depression. It’s here that they spend the majority of their days...
Recognizing treatment resistance early can raise the response rate from 30% to 80% in difficult-to-treat cases. in this video, Jonathan Meyer, MD, shares his top strategies to manage it with Chris Aiken, MD.
Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.
Harnessing this drug interaction can reduce clozapine's metabolic risks, but it needs to be done with care.
We have nearly a dozen atypical antipsychotics to choose from, but do all of these work in bipolar disorder and which of them should we start with? Listen to the podcast.
Bipolar disorder itself is a risk factor for renal impairment, and myths abound about lithium’s effect on the kidneys. Here are tips to mitigate potential damage.
The bipolar word can be frightening or confusing to patients, but there are ways to talk about it that engage them in recovery. More in this podcast.
Hear the latest insights about a popular sweetener that has been linked to mania.
Ask a patient with depression how long it takes for them to feel fully awake in the morning and you are liable to get some revealing answers.